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ABSTRACT 
 
Objective. Health care decision making is a complex process involving many stakeholders and allowing 
for multiple decision criteria. The Analytic Hierarchy process (AHP) can support these complex decisions 
that relate to the application and coverage of health care technologies. The objective of this study is to 
review the past applications of the AHP in supporting health care decision making, and to make 
recommendations for its future use.   
Method. We conducted a systematic review of AHP applications in health care, as described in the 
relevant medical, health-economical, psycho-sociological, managerial, and applied mathematical 
literature.  
Results. We found 62 distinctive AHP applications in health care. Of the retrieved applications, 13 % 
focus on shared decision-making between patient and clinician, 27 % on the development of clinical 
practice guidelines, 5 % on the development of medical devices and pharmaceuticals, 40 % on 
management decisions in health care organizations, and 15 % on the development of national health care 
policy.   
Conclusions. From the review it is concluded that the AHP is suitable to apply in case of complex health 
care decision problems, a need to improve decision making in stead of explain decision outcomes, a need 
to share information among experts or between clinicians and patients, and in case of a limited 
availability of informed respondents. We foresee the increased use of the AHP in health economical 
assessment of technology.  
 
Keywords: Analytic Hierarchy Process, systematic literature review, health care decision making, health 
technology assessment. 
 
 
1. Introduction 
Patients and society poses high and diverse demands on health care interventions. The demands relate to 
medical and economical, social, legal, ethical, organizational or technical criteria. Established methods 
used in Health Technology Assessment or HTA can be roughly divided into clinical trials and economic  
studies. Clinical trials investigate the clinical outcome of health care interventions and build the evidence 
based medicine library. Clinical outcomes include for example mortality and morbidity. Economic 
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evaluations, such as cost-effectiveness or cost-utility analyses, incorporate a broader range of outcome 
measures, such as quality-adjusted life years and willingness to pay, relative to the additional resources 
required for that particular intervention. All methods have in common that they are used to inform 
healthcare decision makers about the coverage and application of health care interventions. The process 
of health care decision making is, however, not only dependent on clinical and economic performance. It 
is a complex and multi-factorial process involving many stakeholders and allowing for different opinions.  
 
Multi-criteria decision analysis (MCDA) can be used to support these complex and multifaceted 
decisions. They help decision-makers to evaluate a finite number of alternative health care interventions 
under a finite number of performance criteria. One validated technique for MCDA is Saaty’s Analytic 
Hierarchy Process (AHP) (Saaty, 1994). Other commonly used tools for multi-criteria or multi-attribute 
decision analysis in health care are the elimination and choice translating reality (ELECTRE), the simple 
multi-attribute rating technique (SMART), multi-attribute utility theory (MAUT), and conjoint analysis. 
Experimental comparisons have been made and concluded that each of the MCDA methods has its own 
advantages and disadvantages. For example, in two studies comparing AHP and conjoint analysis it was 
concluded that AHP has clear advantages in case of complex decisions (Mulye, et al, 1998; Scholl, et al, 
2005). Although much of the work on AHP has been done outside the healthcare sector, some empirical 
applications suggest that the AHP can be an effective tool to support health care decision making about 
the coverage and application of health care interventions (Dolan & Bordley, 1993; Hummel, et al., 1995).   
 
 
2. Objective 
The objective of this study is to review the past use of the AHP in health care decision making. Based on 
the review we aim to provide suggestions on the future use of the AHP in health care decision making and 
on its use for health economic evaluation of new technology in particular. 
 
 
3. Methods 
We conducted a systematic literature review on the use of the Analytic Hierarchy Process (AHP) in health 
care. Within de English language databases of Pub Med and Web of Science we searched in the abstracts 
for the keywords “Analytic Hierarchy Process” AND (“patient” OR “patients” OR “health” OR 
“healthcare” OR “medical” OR “clinical” OR “hospital”). All retrieved abstracts were screened to include 
only those articles that were actually focusing on the AHP methodology and on applications within health 
care. We then summarized the evidence on best practices regarding the decision tasks, patient-relevant 
criteria to include in these tasks, and characteristics of the AHP participants. 
 
4. Results 
We found 93 articles focusing on the use of the AHP in health care. In order to arrange the 62 distinctive 
AHP applications found, we distinguished among five decision task levels. Of the retrieved applications, 
13 % focus on shared decision-making between patient and clinician, 27 % on the development of clinical 
guidelines, 5 % on the development of health care innovations, 40 % on management decisions in health 
care organizations, and 15 % on the development of national health care policy. Table 1, 2, 3, 4 and 5 
describe the AHP applications in these decision areas.  
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Table 1. Shared decision making 
 
In case of shared decision making, this review shows that individual patients can be supported to weight 
the diverse subjective and objective decision criteria. Most commonly, the amount of criteria range from 
5 to 10 decision criteria. The outcomes only represent the preferred choice for the specific patient 
involved. 
 
Table 2. Development of clinical guidelines  
Author Year # crit. # alt. Individual 
or group 
Participants Pairwise comparisons  
or direct rating 
Diagnosis:  
Cook 1990 9 12 group clin icians  direct rating 
Dolan 1993 5 4 individual 25 patients,  
22 clinicians 
pairwise comparisons 
Castro 1996 4 4 individual 6 clinicians pairwise comparisons 
Saaty  1998 11 2 individual clin ician pairwise comparisons 
Koch 1998 
- 
2000 
33 - 4 groups health prof.,  
relatives patients,  
citizens 
direct rating 
Barosi  2007  - Individual and 
group 
- pairwise comparisons 
pairwise comparisons 
Uzoka 2011 22 5 individual 6 clinicians direct rating 
Pecchia epub 35 - individual 191 health prof.  pairwise comparisons 
Treatment: 
Peralta 
Carcelen 
1997 5 2 individual 92 patients,  
80 health prof.  
pairwise comparisons 
pairwise comparisons 
Dolan 1998 9 7 individual 61 clinicians pairwise comparisons 
Carter 1999 14 5 individual 2 clinicians pairwise comparisons 
Kuntz 1999 798 2 Individual and 
group 
9 clinicians pairwise comparisons 
Hummel 2005 24 2 group 7 health prof., patient pairwise comparisons 
 Singh 2006 10 4 - - direct rating 
Van Til 2008 17 6 group 10 health prof.  pairwise comparisons 
Sharma 2011 13 2 individual 96 patients pairwise comparisons 
Clinical performance measurement:  
Kunene 2005 9 - - - direct rating 
Author Year # crit. # alt. Individual 
or group 
Participants Pairwise comparisons  
or direct rating 
Shared decision making:  
Dolan 2002 7 6 individual 46 patients pairwise comparisons 
Liberatore 2003 12 3 group 
individual 
focus group 
60 patients 
pairwise comparisons 
pairwise comparisons 
Richman 2005 9 8 individual 
individual 
12 clinicians 
18 patients 
pairwise comparisons 
Pairwise comparisons Hummel 2005 5 2 individual 34 patients pairwise comparisons 
Katsumura 2008 13 2 individual 353 patients pairwise comparisons 
Van Til  2008 4 2 individual 17 patients pairwise comparisons 
IJzerman 2009 6 5 individual 142 patients pairwise comparisons 
Kitamura 2010 5 2 individual 31 patients pairwise comparisons 
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In case of clinical guidelines, individual clinicians and, if relevant, patients individually compare the 
relative importance’s of the decision criteria. In case of new technology, the importance of the criteria can 
be assessed in a multidisciplinary group session. The criteria analysed commonly range from 10 to 15 
decision criteria.  
 
Table 3. Biomedical innovation 
Author Year # crit. # alt. Individual 
or group 
Participants Pairwise comparisons  
or direct rating 
Technology development:  
Hummel 2000 19 3 group 9 health prof., engineers pairwise comparisons 
Hummel 2000 24 3 group 8 health prof., engineers, 
patient 
pairwise comparisons 
Van der 
Wetering 
2008 14 5 individual 6 health prof., engineers, 
patient, policy makers 
pairwise comparisons 
 
In case of early technology assessment, 15 to 25 decision criteria are assessed in a multidisciplinary group 
composed of clinicians, biomedical engineers and if relevant patients. The outcomes are meant to 
represent a specific group of patients. 
  
Table 4. Health care management 
Author Year # crit. # alt. Individual 
or group 
Participants Pairwise comparisons  
or direct rating 
Equipment procurement:  
Sloane 2003 
2004 
23 3 individual 1 manager, 
1 clin. engineer 
pairwise comparisons 
Balestra 2007 32 - individual 2 clinicians pairwise comparisons 
Wu 2007 24 3 individual 13 administrators, 
researchers 
pairwise comparisons 
Baykasoglu 2009 10 2 group 10 managers, clin icians pairwise comparisons 
Contractor selection:  
Turri 1988 7 3 group hospital committee  pairwise comparisons 
Hsu 2008 22 4 Individual 6 hospital administrator s pairwise comparisons 
Performance measurement of services:  
Bilsel 1996 24 9 individual clients pairwise comparisons 
Longo 2002 11 8 Individual nurses,  clin icians and 
researchers 
pairwise comparisons 
Hariharan 2005 22 3 individual clin icians, managers direct rating 
Dey 2006 25 3 6 groups clin icians, managers pairwise comparisons 
Chang 2006 40 - individual 30 clients pairwise comparisons 
Hsu 2009 17 - individual 303 patients pairwise comparisons 
Ajami epub 44 3 individual researchers pairwise comparisons 
Appropriation of support services:  
Lee 1999 6 9 individual system experts direct rating 
Rossetti 2001 18 2 individual director direct rating 
Da Rocha 2005 4 2 - - direct rating 
Strategic marketing:  
Javalgi 1991 9 3 group managers, clin icians, 
patients 
pairwise comparisons 
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Sinuany-Stern 1995 5 6 individual 11 experts direct rating 
Wu 2005 24 3 individual 13 administrators pairwise comparisons 
Tzung 2007 23 3 individual 207 patients pairwise comparisons 
Ohta 2007 5 9 - - direct rating 
Human resource planning:  
Tavana 1996 13 7 individual and 
group 
12 decision makers pairwise comparisons 
Kwak 1997 59 - individual policy experts pairwise comparisons 
Weingar ten 1997 3 - individual and 
group 
hospital staff pairwise comparisons 
Liao 2009 12  individual 48 hospital staff Pairwise comparisons 
 
In case of management decisions, 15 to 25 decision criteria are generally analyzed in a group of 15 or less 
experts, including health professionals, managers, patients or others. 
 
Table 5. Governmental policy 
Author Year # crit. # alt. Individual 
or group 
Participants Pairwise comparisons  
or direct rating 
Resource allocat ion to healthcare programs:  
Matsuda 1998 6 - - 53 citizens pairwise comparisons 
Grof 2007 5 6 - - - 
Taneja 2007 - - - - - 
Shin 2008 25 2 individual 88 experts pairwise comparisons 
Bi epub 4 40 - - pairwise comparisons 
Policy for new technology:  
Cho 2003 8 88 group 8 clinicians,  
4 engineers 
pairwise comparisons 
Nuijten 2004 3 3 individual few experts pairwise comparisons 
Smith 2010 8 35 individual 4 experts pairwise comparisons 
Societal norms:  
Koch 1998 19 3 group researchers pairwise comparisons 
 
In case of health care policy making, 10 to 15 decision criteria are generally analyzed either by a 
relatively large group of individual experts, or in a group session with 10 or less experts. The outcomes 
are intended to represent the general population, or a target group within this population.   
 
 
5. Conclusions and discussion about the past of the AHP 
From the review it is concluded that the AHP is increasingly being used in health care  and provides 
valuable support in complex healthcare decisions. Most of the applications deal with complex decision 
structures. The most complex decision structures were found at the level of management in health 
organizations, and biomedical innovation. The evaluation of the effects of a new health intervention on 
the health care organization is often represented in complex decision structures. Technologies can be 
evaluated based on the costs, advantages and disadvantages for the groups involved. One appropriate 
application of the AHP involves group discussions between health professionals, managers, patients, or 
others. Likewise, the AHP can support the relatively complex decisions about technological innovations 
about which clinical evidence has not yet been gathered. In this case the technology can be assessed in a 
multidisciplinary group setting with technological developers with state-of-the-art knowledge about the 
new technology, and clinicians. For complex decisions about national health care policy, an alternative 
approach more often applied is to consult individual experts in a Delphi setting.  
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The AHP is also frequently applied to support clinical experts to decide upon clinical guidelines and to 
implement shared decision making. Shared decision making is the process of informing patients and 
eliciting preferences for treatment. If preferences among patients vary widely, or the preferences of the 
patients are likely to differ from the preferences of physicians, the AHP is valuable in this context.  
 
 
6. Recommendations for the future of the AHP  
In general, we recommend the use of the AHP to support the assessment of health care technology in case 
of complex decision problems, a need to improve decision making in stead of explaining decision 
outcomes, a need to share information among experts or between clinicians and patients, and in case of a 
limited availability of informed respondents.  
 
We foresee the increased use of the AHP in conducting comprehensive Health Technology Assessments. 
The literature review has shown that the AHP is a valuable tool to support decision making about new 
health technology. The, consensus based, group decision making process allows a multi-disciplinary team 
of experts to judge the relative importance of the outcome measures of new technologies attributes and to 
reach a conclusion about the overall benefit of the technology being evaluated. In this respect, its main 
advantage is that it allows discussions between panel members and, hence, the exchange of information.      
 
More specifically, AHP can be used to support health economic evaluations of new health care 
technology. Although AHP has primarily been developed to support management decision making, it may 
have a role in (1) prioritizing multiple patient-related outcomes in clinical trials and (2) analyzing the net 
benefit of health interventions. By developing a hierarchical structure of the outcome measures 
considered, it is possible to determine weights for separate and for categories of patient-relevant 
endpoints. This could be done before the benefits assessment, preferentially in a large group of informed 
patients. However, up to now AHP has not often been used for this particular purpose and more research 
is warranted on the applicability of AHP in a survey and the difference with utility based patient-reported 
outcome measures.  
 
 
REFERENCES  
 
Dolan, J.G., & Bordley, D.R. (1993). Involving patients in complex decisions about their care: an 
approach using the analytic hierarchy process. J Gen Intern Med, 8(4), 204-209. 
 
Saaty, T.L. (1994). Highlights and critical points in the theory and application of the Analytic Hierarchy 
Process. European Journal of Operational Research, 74, 426-447.  
 
Mulye, R. (1998). An empirical comparison of three variants of the AHP and two variants of Conjoint 
Analysis. Journal of Behavioral Decision Making, 11, 263-280. 
 
Scholl, A., Manthey, L. Helm, R., & Steiner M. (2005). Solving multiattribute design problems with 
analytic hierarchy process and conjoint analysis: an empirical comparison. European Journal of 
Operational Research, 164, 760-777. 
 
Hummel, J.M., Rossum, W. van, Verkerke, G.J., et al. (2000). Assessing medical technologies in 
development. A new paradigm of medical technology assessment. Int J Technol Assess Health Care, 
16(4),1214-1219. 
 
